NCT05299021

Brief Summary

Nowadays, the incidence of breast cancer is the first number of malignant tumors, and the primary treatment method is surgery. As is known to all, less postoperative complications and enhanced recovery are closely related to effective analgesia. However, postoperative patients often experience moderate pain, while associated with axillary discomfort. Serratus Anterior Plane Block (SAPB) relieves postoperative pain, but traditional single point block method has no effect on axillary discomfort. Therefore, it is necessary to try double point blocks to explore their impact on postoperative analgesia and axillary comfort. This RCT will recruit patients proposed to undergo Modified Radical Mastectomy (MRM) and be randomized to single point or double point groups to evaluate their postoperative pain score and axillary comfort in order to provide clinical guidance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

March 28, 2022

Completed
4 days until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 5, 2023

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2023

Completed
Last Updated

March 6, 2024

Status Verified

December 1, 2023

Enrollment Period

1.7 years

First QC Date

December 6, 2021

Last Update Submit

March 4, 2024

Conditions

Keywords

Mammary CancerSerratus Anterior Plane BlockPostoperative PainAxillary Discomfort

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain severity at 24 h

    Postoperative pain severity at rest and movement measured using a numerical rating scale(NRS) at 24 h. The numerical rating scale (NRS) is a line with numbers from 0 to 10 are spaced evenly across the page. And the NRS is bounded at the left-most end with "no pain" and at the right-most end with "worst pain imaginable". Patients are instructed to circle the number that represents the amount of pain that they are experiencing at the time of the evaluation. The movement status refers to maximum mobility of the upper arm of the surgical side.

    24 hours after the surgery

Secondary Outcomes (3)

  • Pain severity at discharge from PACU and at 6 and 12 and 48 h postoperatively

    Respectively at discharge from PACU and at 6 and 12 and 48 h after the surgery;

  • Postoperative opioid consumption

    Respectively at 24 and 48 h after the surgery;

  • Proportion of rescue analgesia

    48 h after the surgery;

Other Outcomes (4)

  • Postoperative axillary comfort severity

    Respectively at discharge from PACU and at 6 and 12 and 24 and 48 h after the surgery.

  • Postoperative quality of recovery

    Respectively at 24 and 48 h after the surgery.

  • Changes in mean arterial pressure(MAP) and heart rate during skin peeling and axillary node dissection

    Before and after 3 min of incision, before and after 3 min of axillary lymph nodes,respectively.

  • +1 more other outcomes

Study Arms (2)

Double-point SAPB

EXPERIMENTAL

SAPB will be performed simultaneously in both the third and fifth rib levels.

Procedure: Double-point SAPB

Single-point SAPB

EXPERIMENTAL

SAPB will be performed only in the fifth rib level.

Procedure: Single-point SAPB

Interventions

A high-frequency linear probe (6-13 MHz) of the ultrasound machine was used to identify the fifth rib in the midaxillary line. The anatomic landmarks of the block were identified: latissimus dorsi, serratus anterior, and the intercostal muscles in the fourth and fifth intercostal levels. After sterilization and draping, an 20-gauge needle was introduced craniocaudally using an in-plane technique. The needle tip was advanced, targeting the plane between the serratus anterior muscle and the fifth rib. Needle position was confirmed by injection of 1-to-2 mL of saline after negative aspiration. And use the same method targeting the plane between the serratus anterior muscle and the third rib.Under real-time visualization, total 30 mL of 0.375% ropivacaine and 0.5 μ g/kg dexmedetomidine mixture will be injected into the two points with 15 ml separately.

Double-point SAPB

A high-frequency linear probe (6-13 MHz) of the ultrasound machine was used to identify the fifth rib in the midaxillary line. The anatomic landmarks of the block were identified: latissimus dorsi, serratus anterior, and the intercostal muscles in the fourth and fifth intercostal levels. After sterilization and draping, an 20-gauge needle was introduced craniocaudally using an in-plane technique. The needle tip was advanced, targeting the plane between the serratus anterior muscle and the fifth rib. Needle position was confirmed by injection of 1-to-2 mL of saline after negative aspiration.Under real-time visualization, total 30 mL of 0.375% ropivacaine and 0.5μ g/kg dexmedetomidine mixture will be injected.

Single-point SAPB

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsBreast cancer patients
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients are proposed to undergo Modified Radical Mastectomy
  • Patients with American Society of Anesthesiologists (ASA) physical status I\~III
  • aged 18-70 years
  • BMI ≤ 35 kg/m2

You may not qualify if:

  • Patients with a pre-existing neuropathy or sensory deficit affecting the operative region
  • Pregnancy
  • Chronic pain or opioid dependence (at least 30 mg of oxycodone or equivalent per day)
  • Allergy to local anaesthesia or any component of the proposed multimodal analgesia regimen
  • Local or systemic contra-indications to peripheral nerve blocks (local infection at the puncture site, coagulopathy, platelets less than 80\*10\^9/L and prothrombin time more than 15 s)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, 200032, China

Location

Related Publications (1)

  • Xu J, Ling D, Xu Q, Sun P, Wei S, Gao L, Lou F, Zhang J. Ultrasound-Guided Double-Point Versus Single-Point Serratus Anterior Plane Block for Modified Radical Mastectomy: A Randomized Controlled Trial. Clin J Pain. 2025 Jan 1;41(1):e1256. doi: 10.1097/AJP.0000000000001256.

MeSH Terms

Conditions

Breast NeoplasmsPain, Postoperative

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Jun Zhang, PhD

    Fudan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the department of anaesthesiology, Shanghai cancer center

Study Record Dates

First Submitted

December 6, 2021

First Posted

March 28, 2022

Study Start

April 1, 2022

Primary Completion

December 5, 2023

Study Completion

December 8, 2023

Last Updated

March 6, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations